title: The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
abstract: There is no doubt about the value of exogenous insulin for people with type 1 diabetes. The purpose of this commentary is to discuss emerging evidence that this may not be the case for the majority of people with type 2 diabetes.
authors: School of Medicine, Cardiff University, Cardiff, UK. currie@cardiff.ac.uk
authors: C J
authors: CJ
authors: Currie
authors: J A
authors: JA
authors: Johnson
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D018570:Risk Assessment
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin